InfuSystems Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $9.9
- Today's High:
- $10.055
- Open Price:
- $10.008
- 52W Low:
- $6.1
- 52W High:
- $11.44
- Prev. Close:
- $9.91
- Volume:
- 13717
Company Statistics
- Market Cap.:
- $208.65 million
- Book Value:
- 2.373
- Revenue TTM:
- $118.09 million
- Operating Margin TTM:
- 2.64%
- Gross Profit TTM:
- $62.48 million
- Profit Margin:
- 0.56%
- Return on Assets TTM:
- 1.93%
- Return on Equity TTM:
- 1.37%
Company Profile
InfuSystems Holdings Inc had its IPO on 2007-12-27 under the ticker symbol INFU.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. InfuSystems Holdings Inc has a staff strength of 420 employees.
Stock update
Shares of InfuSystems Holdings Inc opened at $10.01 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $9.9 - $10.06, and closed at $9.99.
This is a +0.81% increase from the previous day's closing price.
A total volume of 13,717 shares were traded at the close of the day’s session.
In the last one week, shares of InfuSystems Holdings Inc have slipped by -2.73%.
InfuSystems Holdings Inc's Key Ratios
InfuSystems Holdings Inc has a market cap of $208.65 million, indicating a price to book ratio of 3.7029 and a price to sales ratio of 1.71.
In the last 12-months InfuSystems Holdings Inc’s revenue was $118.09 million with a gross profit of $62.48 million and an EBITDA of $15.85 million. The EBITDA ratio measures InfuSystems Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, InfuSystems Holdings Inc’s operating margin was 2.64% while its return on assets stood at 1.93% with a return of equity of 1.37%.
In Q2, InfuSystems Holdings Inc’s quarterly earnings growth was a negative -50.5% while revenue growth was a positive 17.4%.
InfuSystems Holdings Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 247.75
- PEG
- 0
Its diluted EPS in the last 12-months stands at $0.04 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into InfuSystems Holdings Inc’s profitability.
InfuSystems Holdings Inc stock is trading at a EV to sales ratio of 1.999 and a EV to EBITDA ratio of 13.4154. Its price to sales ratio in the trailing 12-months stood at 1.71.
InfuSystems Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $102.75 million
- Total Liabilities
- $12.87 million
- Operating Cash Flow
- $-2339000.00
- Capital Expenditure
- $3.20 million
- Dividend Payout Ratio
- 0%
InfuSystems Holdings Inc ended 2024 with $102.75 million in total assets and $0 in total liabilities. Its intangible assets were valued at $102.75 million while shareholder equity stood at $49.96 million.
InfuSystems Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $12.87 million in other current liabilities, 2000.00 in common stock, $-59386000.00 in retained earnings and $3.71 million in goodwill. Its cash balance stood at $134000.00 and cash and short-term investments were $134000.00. The company’s total short-term debt was $0 while long-term debt stood at $36.14 million.
InfuSystems Holdings Inc’s total current assets stands at $28.63 million while long-term investments were $1.91 million and short-term investments were $0. Its net receivables were $18.87 million compared to accounts payable of $5.48 million and inventory worth $5.71 million.
In 2024, InfuSystems Holdings Inc's operating cash flow was $-2339000.00 while its capital expenditure stood at $3.20 million.
Comparatively, InfuSystems Holdings Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $9.99
- 52-Week High
- $11.44
- 52-Week Low
- $6.1
- Analyst Target Price
- $15.17
InfuSystems Holdings Inc stock is currently trading at $9.99 per share. It touched a 52-week high of $11.44 and a 52-week low of $11.44. Analysts tracking the stock have a 12-month average target price of $15.17.
Its 50-day moving average was $10.31 and 200-day moving average was $9.35 The short ratio stood at 7.73 indicating a short percent outstanding of 0%.
Around 532.6% of the company’s stock are held by insiders while 7576.1% are held by institutions.
Frequently Asked Questions About InfuSystems Holdings Inc
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.